Endo International PLC (NASDAQ:ENDP)

68.34
Data as of Sep 30
 -1.18 / -1.70%
Today’s Change
43.12
Today|||52-Week Range
82.16
+1.30%
Year-to-Date
GlycoMimetics Down Due to Delay in Rivipansel Study - Analyst Blog
Sep 30 / Zacks.com
ZS Pharma Gains on Positive Phase III Hyperkalemia Results - Analyst Blog
Sep 24 / Zacks.com
Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog
Sep 29 / Zacks.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - A...
Sep 24 / Zacks.com
Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog
Sep 29 / Zacks.com
ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher - Tale of the Tape
Sep 24 / Zacks.com
Pacira Down on Receipt of FDA Warning Letter for Exparel - Analyst Blog
Sep 29 / Zacks.com
Salix Pharmaceuticals (SLXP) in Focus: Stock Up 5.8% - Tale of the Tape
Sep 24 / Zacks.com
Cempra (CEMP) Jumps: Stock Up 8.9% in Session - Tale of the Tape
Sep 29 / Zacks.com
Radius Health (RDUS) in Focus: Stock Surges 17.3% - Tale of the Tape
Sep 24 / Zacks.com
Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher - Tale of the Tape
Sep 29 / Zacks.com
Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog
Sep 23 / Zacks.com
Karyopharm Therapeutics, Inc. (KPTI) Surges: Stock Adds 10.5% - Tale of the Tape
Sep 29 / Zacks.com
Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog
Sep 23 / Zacks.com
Cerulean Pharma (CERU) Jumps: Stock Up 9.8% in Session - Tale of the Tape
Sep 29 / Zacks.com
Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog
Sep 19 / Zacks.com
Alnylam Starts New Study on Cardiac Amyloidosis Patients - Analyst Blog
Sep 26 / Zacks.com
Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog
Sep 19 / Zacks.com
IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session - Tale of the Tape
Sep 26 / Zacks.com
Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog
Sep 19 / Zacks.com
BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog
Sep 25 / Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
Sep 19 / Zacks.com
Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog
Sep 25 / Zacks.com
Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape
Sep 19 / Zacks.com
Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% - Tale of the Tape
Sep 25 / Zacks.com
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog
Sep 18 / Zacks.com
Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% - Tale of the Tape
Sep 25 / Zacks.com
Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape
Sep 18 / Zacks.com
Galmed's Aramchol Gets Fast-Track Designation in the U.S. - Analyst Blog
Sep 24 / Zacks.com
Endo Looking to Acquire Auxilium Pharmaceuticals for $2.2B - Analyst Blog
Sep 17 / Zacks.com
Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog
Sep 24 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.